Menu Back toOS01: Big expectation for International Harmonization by ICH Q12 Implementation
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
18th DIA Japan Annual Meeting 2021
All prices are exclusive of 10% Japanese consumption tax
OS01: Big expectation for International Harmonization by ICH Q12 Implementation
Takayuki Imaeda, MPharm, MS
- Head of Regulatory Affairs
- Pfizer R&D Japan, Japan
Timothy Watson, PhD
- Vice-Chair & Executive Director, GCMC
- IQ Consortium & Pfizer, United States
- Director, Head
- GlaxoSmithKline K.K., Japan